Chemed Stock-Based Compensation Growth & History (CHE)
Chemed's stock-based compensation was $38.7M for fiscal 2025.
View full Chemed company overviewChemed annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $38.7M | −$13.4M | −25.77% |
| 2024 | 2024-12-31 | $52.1M | $11.3M | +27.74% |
| 2023 | 2023-12-31 | $40.8M | $7.2M | +21.36% |
| 2022 | 2022-12-31 | $33.6M | $2.2M | +6.98% |
| 2021 | 2021-12-31 | $31.4M | $4.6M | +17.23% |
| 2020 | 2020-12-31 | $26.8M | $5.5M | +25.61% |
| 2019 | 2019-12-31 | $21.3M | $2.1M | +10.97% |
| 2018 | 2018-12-31 | $19.2M | $3.0M | +18.29% |
| 2017 | 2017-12-31 | $16.3M | $2.5M | +18.03% |
| 2016 | 2016-12-31 | $13.8M | −$964,000 | −6.54% |
| 2015 | 2015-12-31 | $14.7M | $4.4M | +42.76% |
| 2014 | 2014-12-31 | $10.3M | −$545,000 | −5.01% |
| 2013 | 2013-12-31 | $10.9M | −$1.1M | −9.24% |
| 2012 | 2012-12-31 | $12.0M | −$2.3M | −15.90% |
| 2011 | 2011-12-31 | $14.2M | −$724,000 | −4.84% |
| 2010 | 2010-12-31 | $15.0M | — | — |
Chemed quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $9.2M | $158,000 | +1.74% |
| Q4 2025 | 2025-12-31 | $8.3M | — | — |
| Q3 2025 | 2025-09-30 | $6.1M | — | — |
| Q2 2025 | 2025-06-30 | $9.2M | — | — |
| Q1 2025 | 2025-03-31 | $9.1M | — | — |
Chemed stock-based compensation trends
Over the last five fiscal years, Chemed's stock-based compensation increased from $26.8M to $38.7M, a change of $11.9M. The latest reported quarter, Q1 2026, shows $9.2M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemed source filings ↗